Chevy Chase Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-238,745
Closed -$19.1M 685
2016
Q4
$19.1M Buy
238,745
+982
+0.4% +$77.9K 0.1% 229
2016
Q3
$19M Sell
237,763
-5,081
-2% -$410K 0.1% 229
2016
Q2
$18.9M Buy
242,844
+3,222
+1% +$230K 0.11% 226
2016
Q1
$13.2M Buy
239,622
+6,308
+3% +$344K 0.08% 293
2015
Q4
$14.4M Buy
233,314
+2,320
+1% +$146K 0.08% 269
2015
Q3
$14.6M Buy
230,994
+9,310
+4% +$664K 0.09% 258
2015
Q2
$16.2M Buy
221,684
+1,693
+0.8% +$122K 0.1% 238
2015
Q1
$14.4M Buy
219,991
+4,130
+2% +$275K 0.09% 271
2014
Q4
$14M Sell
215,861
-1,218
-0.6% -$78.4K 0.09% 264
2014
Q3
$13.1M Buy
217,079
+13,646
+7% +$891K 0.08% 264
2014
Q2
$14.1M Sell
203,433
-3,956
-2% -$256K 0.1% 231
2014
Q1
$13.6M Sell
207,389
-5,472
-3% -$356K 0.1% 237
2013
Q4
$13.2M Buy
212,861
+6,220
+3% +$360K 0.1% 234
2013
Q3
$11.1M Buy
206,641
+7,162
+4% +$369K 0.09% 265
2013
Q2
$9.1M Buy
+199,479
New +$8.64M 0.08% 290

Other funds holding STJ

Chevy Chase Trust's STJ Position: Q1 2017 in Review

Chevy Chase Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 238,745 shares — an estimated $19.1M sold.

Chevy Chase Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $19.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Chevy Chase Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Chevy Chase Trust sold 238,745 St Jude Medical shares in Q1 2017, an estimated $19.1M.
  • Chevy Chase Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Chevy Chase Trust's St Jude Medical position peaked at $19.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Chevy Chase Trust's 13F filing for Q1 2017, filed 5 Apr 2017.